Two leading female entrepreneurs have joined forces to bring two new rapid result Covid-19 tests to the UK market.

The diagnostic finger-prick antibody testing kits return a result in 10 minutes and can determine if people currently have the virus, or have had it, by identifying antibodies developed against the virus.

The antigen tests detect virus DNA which can be identified from day one of infection, with the tests returning a result in 15 minutes.

As infection rates rise across the UK, one company believes its quick turnaround of mass antibody and antigen testing could prove crucial in allowing businesses, travel and events to continue operating as normal.

With tests having already been made available by Chanelle McCoy Health Ltd in Ireland, Cheltenham based CHB Medical, founded by Felicity Griffiths, has partnered with them to bring the tests to the UK.

The partnership was forged by Lee Moulson, global head of sales at CHB Medical, who has admired McCoy Health's work in the pharmaceutical world for a number of years.

Mr Moulson identified that joining forces another female-led business would be a recipe for success and as such the distribution channel was born and roll-out in the UK is already underway.

Felicity Griffiths, founder and CEO of CHB Medical, said: "We're thrilled to be working in partnership with Chanelle McCoy Health Ltd to bring these new rapid antibody and antigen diagnostic tests to the UK market.

"Our team is working to provide bespoke packages for businesses on an enquiry-by-enquiry basis, we are able to scale-up our offering in line with the needs of an organisation, and the tests are compatible with private health passports."

Lady McCoy, founder and CEO of Chanelle McCoy Health, is an investor on Dragons Den in Ireland and says that mass testing regimes are key to controlling Covid-19 in the future.

She said: "We are delighted to be working with CHB Medical as our UK distributors of what is the most accurate and widely used Covid-19 rapid testing kit available on the market.

"CHB Medical has been selected as our partners due to their vast market experience and successes, professionalism and enthusiasm for the product, and shared vision that the future of COVID-19 control will undoubtedly lie in mass testing regimes."